Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berinert pharmacokinetics and safety in hereditary angioedema with congenital C1 inhibitor deficiency
2010-019670-32Phase 3Active
- Sponsor
- Luigi Sacco University Hospital
- Start
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by Luigi Sacco University Hospital. Primary endpoint: Pharmacokinetics of intravenous study medication at steady state. Started Dec 2012; status: active.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on 2010-019670-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019670-32.